The Best Nasdaq Stock Today

Plus, Helios and Matheson Analytics is making another huge move

by Josh Selway

Published on Dec 12, 2017 at 1:54 PM

U.S. stocks are rallying once again, with the Dow and S&P 500 Index (SPX) hitting a record highs. Among the names making big moves are biotech Proteostasis Therapeutics Inc (NASDAQ:PTI), oil-and-gas issue Oasis Petroleum Inc. (NYSE:OAS), and IT stock Helios and Matheson Analytics Inc (NASDAQ:HMNY). Here's a quick look at what's moving shares of PTI, OAS, and HMNY.

PTI Stock is Today's Top Nasdaq Performer

Up 165.5% today at $6.24, Proteostasis Therapeutics is by far the biggest percentage gainer on the Nasdaq today. The rally comes after the company yesterday announced positive trial results for its cystic fibrosis treatments. PTI is now trading above its 200-day moving average for the first time since March, though it's still well below its February peak of $16.67. Meanwhile, Leerink and Baird raised their respective price targets to $8 and $25. Most analysts are already bullish on the biotech stock, with all three covering brokerage firms issuing "strong buy" ratings.

Analysts React to Oasis Petroleum Land Purchase

Shares of Oasis Petroleum are down 15.1% today at $8.54, after the company announced a public stock offering of 32 million common shares to help fund the purchase of additional land in the Delaware Basin. This price action puts OAS back below the formerly supportive 50-day moving average and brings its 12-month deficit to 45.3%.

Meanwhile, analyst reactions today have been mixed. While SunTrust Robinson downgraded Oasis Petroleum to "hold" from "buy," RBC was one of three brokerage firms to raise its price target, setting the bar at $14, though the latter said the company's biggest hurdle will be execution in the Permian Basin.

In the options pits, traders were showing bullish expectations coming into today. This is according to the security's 10-day call/put volume ratio of 13.23 across the International Securities Exchange (ISE), Chicago Board Options Exchange (CBOE), and NASDAQ OMX PHLX (PHLX) -- though volume has been muted on an absolute basis.

HMNY Stock Makes Another Huge Move

Helios and Matheson Analytics stock has picked up 10.4% to trade at $10.08, thanks to news its MoviePass business inked a deal with retailer Costco (COST), offering customers a year-long subscription for $89.99. The shares have been prone to making big moves over the past year, despite negative attention from short seller Citron Research. Overall, HMNY is up 205% in 2017, but remains far below its October peak of $38.86. Interestingly, not a single analyst is covering this volatile stock.

A Schaeffer's exclusive


Access your FREE insider report before it's too late!



NEW! Explore Schaeffer’s Partners' deals and get connected to top online brokerages with deals tailored exclusively for our readers.  Get answers to your questions regarding transfer fees, commission rates, programs and available discounts related to online trading services.

MORE | MARKETstories

One "Monday Morning Payday" Trick Nets Investors Thousands in Profit
Click to continue to advertiser's site.
AMD Hits Record High on Double Dose of Bull Notes
AMD has been a long-term outperformer
Costco Stock at New High on Oppenheimer Upgrade
Short interest on COST is at the highest point since March
One "Monday Morning Payday" Trick Nets Investors Thousands in Profit
Click to continue to advertiser's site.